Bio Green Med
BGMS
Bio Green Med (BGMS) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.98
- EPS estimate
- −$72.00
- EPS surprise
- +98.64%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $25,000.00
- Reported
- Aug 13, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 13, 2025 | −$72.00 | −$0.98 | +98.64% | $0.00 | SEC |
| Q1 2025 | May 14, 2025 | −$69.60 | $0.00 | +100.00% | $0.00 | SEC |
| Q4 2024 | Apr 2, 2025 | −$69.60 | −$79.20 | −13.79% | $10,000.00 | SEC |
| Q3 2024 | Nov 12, 2024 | −$129.60 | −$43.20 | +66.67% | $10,000.00 | SEC |
| Q2 2024 | Aug 14, 2024 | −$344.40 | −$172.80 | +49.83% | $4,000.00 | SEC |
| Q1 2024 | May 14, 2024 | −$1,138.80 | −$544.80 | +52.16% | $29,000.00 | SEC |
| Q4 2023 | Mar 19, 2024 | −$1,414.40 | −$1,495.20 | −5.71% | $31,000.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$1,308.00 | −$1,764.00 | −34.86% | $16,000.00 | SEC |
| Q2 2023 | Aug 9, 2023 | −$1,812.00 | −$1,584.00 | +12.58% | $373,000.00 | SEC |
| Q1 2023 | May 11, 2023 | −$2,388.00 | −$1,692.00 | +29.15% | $0.00 | SEC |
| Q4 2022 | Mar 6, 2023 | −$1,737.00 | −$2,160.00 | −24.35% | $0.00 | SEC |
| Q3 2022 | Nov 9, 2022 | −$1,836.00 | −$1,512.00 | +17.65% | $0.00 | — |
| Q2 2022 | Aug 10, 2022 | −$1,935.00 | −$1,656.00 | +14.42% | $0.00 | — |
| Q1 2022 | May 11, 2022 | −$2,466.00 | −$1,512.00 | +38.69% | $0.00 | — |
| Q4 2021 | Mar 28, 2022 | −$2,466.00 | −$1,944.00 | +21.17% | $0.00 | — |
| Q3 2021 | Nov 10, 2021 | −$2,520.00 | −$1,944.00 | +22.86% | $0.00 | — |
| Q2 2021 | Aug 11, 2021 | −$1,836.00 | −$2,016.00 | −9.80% | $0.00 | — |
| Q1 2021 | May 12, 2021 | −$1,752.00 | −$1,800.00 | −2.74% | $0.00 | — |
| Q4 2020 | Feb 25, 2021 | −$1,908.00 | −$4,824.00 | −152.83% | $0.00 | — |
| Q3 2020 | Nov 12, 2020 | −$1,980.00 | −$1,692.00 | +14.55% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Bio Green Med (BGMS) last report earnings?
Bio Green Med last reported on Aug 13, 2025, covering fiscal Q2 2025.
Did BGMS beat earnings estimates?
Yes. Bio Green Med reported EPS of −$0.98 for Q2 2025 against a −$72.00 estimate — a 98.64% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.